Epigenetic silencing of DSC3 is a common event in human breast cancer
- PMID: 16168112
- PMCID: PMC1242132
- DOI: 10.1186/bcr1273
Epigenetic silencing of DSC3 is a common event in human breast cancer
Abstract
Introduction: Desmocollin 3 (DSC3) is a member of the cadherin superfamily of calcium-dependent cell adhesion molecules and a principle component of desmosomes. Desmosomal proteins such as DSC3 are integral to the maintenance of tissue architecture and the loss of these components leads to a lack of adhesion and a gain of cellular mobility. DSC3 expression is down-regulated in breast cancer cell lines and primary breast tumors; however, the loss of DSC3 is not due to gene deletion or gross rearrangement of the gene. In this study, we examined the prevalence of epigenetic silencing of DSC3 gene expression in primary breast tumor specimens.
Methods: We used bisulfite genomic sequencing to analyze the methylation state of the DSC3 promoter region from 32 primary breast tumor specimens. We also used a quantitative real-time RT-PCR approach, and analyzed all breast tumor specimens for DSC3 expression. Finally, in addition to bisulfite sequencing and RT-PCR, we used an in vivo nuclease accessibility assay to determine the chromatin architecture of the CpG island region from DSC3-negative breast cancer cells lines.
Results: DSC3 expression was downregulated in 23 of 32 (72%) breast cancer specimens comprising: 22 invasive ductal carcinomas, 7 invasive lobular breast carcinomas, 2 invasive ductal carcinomas that metastasized to the lymph node, and a mucoid ductal carcinoma. Of the 23 specimens showing a loss of DSC3 expression, 13 (56%) were associated with cytosine hypermethylation of the promoter region. Furthermore, DSC3 expression is limited to cells of epithelial origin and its expression of mRNA and protein is lost in a high proportion of breast tumor cell lines (79%). Lastly, DNA hypermethylation of the DSC3 promoter is highly correlated with a closed chromatin structure.
Conclusion: These results indicate that the loss of DSC3 expression is a common event in primary breast tumor specimens, and that DSC3 gene silencing in breast tumors is frequently linked to aberrant cytosine methylation and concomitant changes in chromatin structure.
Figures






Similar articles
-
Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.PLoS One. 2014 Mar 24;9(3):e92815. doi: 10.1371/journal.pone.0092815. eCollection 2014. PLoS One. 2014. PMID: 24664224 Free PMC article. Clinical Trial.
-
DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.Br J Cancer. 2011 Mar 15;104(6):1013-9. doi: 10.1038/bjc.2011.28. Epub 2011 Mar 1. Br J Cancer. 2011. PMID: 21364582 Free PMC article.
-
ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.BMC Cancer. 2009 Mar 6;9:80. doi: 10.1186/1471-2407-9-80. BMC Cancer. 2009. PMID: 19267929 Free PMC article.
-
Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas.J Cancer. 2014 May 14;5(6):457-64. doi: 10.7150/jca.9145. eCollection 2014. J Cancer. 2014. PMID: 24847386 Free PMC article.
-
The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.Carcinogenesis. 2012 Dec;33(12):2326-33. doi: 10.1093/carcin/bgs273. Epub 2012 Aug 31. Carcinogenesis. 2012. PMID: 22941060
Cited by
-
Agglomerative epigenetic aberrations are a common event in human breast cancer.Cancer Res. 2008 Oct 15;68(20):8616-25. doi: 10.1158/0008-5472.CAN-08-1419. Cancer Res. 2008. PMID: 18922938 Free PMC article.
-
Cell Adhesion Molecules Affected by Ionizing Radiation and Estrogen in an Experimental Breast Cancer Model.Int J Mol Sci. 2022 Oct 21;23(20):12674. doi: 10.3390/ijms232012674. Int J Mol Sci. 2022. PMID: 36293530 Free PMC article.
-
Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice.PLoS One. 2012;7(11):e50024. doi: 10.1371/journal.pone.0050024. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185521 Free PMC article.
-
Desmocollin switching in colorectal cancer.Br J Cancer. 2006 Nov 20;95(10):1367-70. doi: 10.1038/sj.bjc.6603453. Epub 2006 Oct 31. Br J Cancer. 2006. PMID: 17088906 Free PMC article.
-
Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.PLoS One. 2014 Mar 24;9(3):e92815. doi: 10.1371/journal.pone.0092815. eCollection 2014. PLoS One. 2014. PMID: 24664224 Free PMC article. Clinical Trial.
References
-
- Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA56666/CA/NCI NIH HHS/United States
- P30 CA23074/CA/NCI NIH HHS/United States
- R29 CA073612/CA/NCI NIH HHS/United States
- T32 ES007091/ES/NIEHS NIH HHS/United States
- P01 CA056666/CA/NCI NIH HHS/United States
- T32 CA09213/CA/NCI NIH HHS/United States
- CA75152/CA/NCI NIH HHS/United States
- R01 CA065662/CA/NCI NIH HHS/United States
- R29 CA065662/CA/NCI NIH HHS/United States
- CA73612/CA/NCI NIH HHS/United States
- ES07091/ES/NIEHS NIH HHS/United States
- P30 CA023074/CA/NCI NIH HHS/United States
- CA65662/CA/NCI NIH HHS/United States
- R01 CA073612/CA/NCI NIH HHS/United States
- R56 CA073612/CA/NCI NIH HHS/United States
- T32 CA009213/CA/NCI NIH HHS/United States
- R01 CA075152/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous